KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) related to its sale to Chiesi Group. Under the terms of the proposed transaction, KalVista shareholders are expected to receive $27.00 per share in cash.
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) related to its sale to Chiesi Group. Under the terms of the proposed transaction, KalVista shareholders are expected to receive $27.00 per share in cash.